Table 2 Process and outcomes indicators for the management of HVA patients

1

% of patients with severe anaphylaxis receiving acute adrenaline treatment in emergency room (ER)

Process

Percent

2

% of patients discharged from ER. with allergological evaluation indication

Process

Percent

3

% of patients prescribed a second adrenaline auto-injector if clinically indicated (patients with mast cell diseases and/or with increased baseline serum tryptase levels, previous need for more than one dose of adrenaline before reaching the hospital, almost fatal previous anaphylaxis, lack of rapid access to anaphylaxis medical assistance due to geographical or linguistic barriers, patient’s habitus)

Process

Percent

4

% of patients with multiple positivity in whom complete CRD was performed

Process

Percent

5

% of patients with severe anaphylactic reaction with syncopal episode without urticaria and/or angioedema and a REMA score ≥ 2 initiated for mastocytosis diagnostic investigations

Process

Percent

6

% of patients with Hymenoptera venom allergy, myocardial infarction or severe ventricular arrhythmia undergoing VIT

Process

Percent